The Health Sciences Authority (HSA) Singapore published minor update of guidance document entitled GN-20 R2 Guidance on Clinical Evaluation on 01 November 2022, stipulating clinical investigations carried out by or on behalf of product owner are encouraged and expected to be designed, conducted, and reported in accordance with international ISO 14155 – Clinical

In line with GDPMDS, HSA Singapore also published minor updates of guidance document entitled GN-06 R3 Guidance on Distribution Records on 01 Nov 2022 which assist product owners on the determination of projected useful life of the medical device. Projected useful life of a medical device is dependent on various

Health Sciences Authority (HSA) Singapore has reviewed and validated the medical device guidance document entitled GN-33 R1.2 Guidance on the Application of Singapore Standard Good Distribution Practice for Medical Devices Revision 1.2 on 01 Nov 2022 to ensure its accuracy. This guidance document serves to provide advice for application of

The Health Sciences Authority (HSA) Singapore published a minor update to guidance document, GN-32: GUIDANCE on Labelling for Medical Devices Rev 2 (dated September 2022). This update provides alignment to GN-36: Guidance on Medical Device Unique Device Identification (UDI) System mandating the UDI compliance for medical devices in Singapore. The